Biotech Doses, Funding, and Deals
Kilder
- STAT: STAT+: Are cancer patients getting too much drug?
- Endpoints: As Trump 2.0 targets federal research, a new study shows the stakes
- Taxfoundation: Tracking the Impact of the Trump Tariffs & Trade War - Tax Foundation
- Labiotech: The cost of waiting: what licensing a biotech asset early really saves you
- BioPharma Dive: Shareholder pressures Capricor; Lilly dives deeper into vaccines
- Finance: Shareholder pressures Capricor; Lilly dives deeper into vaccines - Yahoo Finance
- Endpoints: Chronic pain biotech co-founded by Vivek Ramaswamy joins reverse merger train
- Bizjournals: Watertown biotech agrees to reverse merger with Vivek Ramaswamy-backed startup - The Business Journals
- wikimedia: Photo by NIH Image Gallery from Bethesda, Maryland, USA / Wikimedia Commons / Public domain
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.